Menu
Back to Journals » Journal of Inflammation Research » Volume 14
Clinical Trial Report
Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,099 | Dovepress* | 4,647+ | 244 | 4,891 | |
| PubMed Central* | 452 | 214 | 666 | ||
| Totals | 5,099 | 458 | 5,557 | ||
| *Since 14 October 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 3 | 0 | 0 | 0 | 1 | 2 |
View citations on PubMed Central and Google Scholar